Testing effectiveness (Phase 2)Study completedNCT00249262What this trial is testingTaxoprexin Treatment for Advanced Skin MelanomaWho this might be right forMetastatic Melanoma American Regent, Inc. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02068586What this trial is testingSunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal MelanomaWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+9 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 210
Very early researchEnded earlyNCT01730157What this trial is testingRadioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver MetastasesWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeExtraocular Extension Melanoma+5 more Case Comprehensive Cancer Center 6
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00003802What this trial is testingPyrazoloacridine in Treating Patients With Metastatic Skin or Eye MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Ended earlyNCT03865212What this trial is testingModified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Choroid Melanoma+10 more Mayo Clinic 12
Large-scale testing (Phase 3)Looking for participantsNCT07804186What this trial is testingStudy of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal MelanomaWho this might be right forUveal Melanoma IDEAYA Biosciences 450
Early research (Phase 1)Study completedNCT00313508What this trial is testingDendritic Cell Vaccination During Lymphoid ReconstructionWho this might be right forIntraocular MelanomaMelanoma (Skin) H. Lee Moffitt Cancer Center and Research Institute 18
Not applicableStudy completedNCT00351728What this trial is testingCombined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning AloneWho this might be right forOcular MelanomaChoroidal MelanomaUveal Melanoma Jonsson Comprehensive Cancer Center 174
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00003022What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00110123What this trial is testingIntravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye MelanomaWho this might be right forIntraocular MelanomaMetastatic Cancer European Organisation for Research and Treatment of Cancer - EORTC 171
Early research (Phase 1)Study completedNCT00705640What this trial is testingVaccine Therapy in Treating Patients With Advanced MelanomaWho this might be right forIntraocular MelanomaMalignant Conjunctival NeoplasmMelanoma (Skin) Craig L Slingluff, Jr 45
Early research (Phase 1)Study completedNCT00020267What this trial is testingVaccine Therapy in Treating Patients With Metastatic CancerWho this might be right forLung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more National Cancer Institute (NCI)
Large-scale testing (Phase 3)Looking for participantsNCT07015190What this trial is testingNeoadjuvant Darovasertib in Primary Uveal MelanomaWho this might be right forUveal Melanoma IDEAYA Biosciences 520
Testing effectiveness (Phase 2)Study completedNCT00084656What this trial is testingMonoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) Bristol-Myers Squibb 77
Testing effectiveness (Phase 2)Study completedNCT00085189What this trial is testingVaccine Therapy in Treating Patients With Stage IIC-IV MelanomaWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeExtraocular Extension Melanoma+14 more University of Southern California 42
Testing effectiveness (Phase 2)Study completedNCT00445965What this trial is testingIodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Study completedNCT00471471What this trial is testingVaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryWho this might be right forIntraocular MelanomaMalignant Conjunctival NeoplasmMelanoma (Skin) Ahmad Tarhini 22
Testing effectiveness (Phase 2)Ended earlyNCT00482911What this trial is testingLenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye MelanomaWho this might be right forIntraocular MelanomaMalignant Conjunctival Neoplasm National Institutes of Health Clinical Center (CC) 12